DK110879A - Ornithin-og argininsalte af forgrenede keto-syrer fremgangsmaade til fremstilling deraf samt deres anvendelse - Google Patents

Ornithin-og argininsalte af forgrenede keto-syrer fremgangsmaade til fremstilling deraf samt deres anvendelse

Info

Publication number
DK110879A
DK110879A DK110879A DK110879A DK110879A DK 110879 A DK110879 A DK 110879A DK 110879 A DK110879 A DK 110879A DK 110879 A DK110879 A DK 110879A DK 110879 A DK110879 A DK 110879A
Authority
DK
Denmark
Prior art keywords
ornithin
acides
procedures
preparation
arginine salts
Prior art date
Application number
DK110879A
Other languages
English (en)
Other versions
DK153542B (da
DK153542C (da
Inventor
M K Walser
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of DK110879A publication Critical patent/DK110879A/da
Publication of DK153542B publication Critical patent/DK153542B/da
Application granted granted Critical
Publication of DK153542C publication Critical patent/DK153542C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185Saturated compounds having only one carboxyl group and containing keto groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK110879A 1978-03-17 1979-03-16 Analogifremgangsmaade til fremstilling af ornithin- eller argininsalte af forgrenede alfa-keto-syrer DK153542C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/887,570 US4228099A (en) 1978-03-17 1978-03-17 Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
US88757078 1978-03-17

Publications (3)

Publication Number Publication Date
DK110879A true DK110879A (da) 1979-09-18
DK153542B DK153542B (da) 1988-07-25
DK153542C DK153542C (da) 1988-12-05

Family

ID=25391422

Family Applications (1)

Application Number Title Priority Date Filing Date
DK110879A DK153542C (da) 1978-03-17 1979-03-16 Analogifremgangsmaade til fremstilling af ornithin- eller argininsalte af forgrenede alfa-keto-syrer

Country Status (17)

Country Link
US (1) US4228099A (da)
JP (1) JPS5838421B2 (da)
AU (1) AU517505B2 (da)
BE (1) BE874900A (da)
CA (1) CA1115729A (da)
DE (1) DE2910221A1 (da)
DK (1) DK153542C (da)
ES (1) ES478710A1 (da)
FI (1) FI72118C (da)
FR (1) FR2419723A1 (da)
GB (1) GB2017094B (da)
IE (1) IE48336B1 (da)
IT (1) IT1202904B (da)
LU (1) LU81057A1 (da)
NL (1) NL7902136A (da)
NO (1) NO151119C (da)
SE (1) SE446724B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof
DE3438455A1 (de) * 1984-10-19 1986-06-26 Institut Dr. Ziegler, Bettingen L-lysin- und l-histidinpyruvat
US4677121A (en) * 1985-01-22 1987-06-30 The Johns Hopkins University Method of inhibiting muscle protein degradation
US4752619A (en) * 1985-12-23 1988-06-21 The Johns Hopkins University Nutritional supplement for treatment of uremia
US4871552A (en) * 1986-09-25 1989-10-03 W. R. Grace & Co.-Conn. Hydantoins as animal food supplements
US4744990A (en) * 1986-09-25 1988-05-17 W. R. Grace & Co. Hydantoins as animal food supplements
US5639731A (en) * 1987-05-22 1997-06-17 Pripps Bryggerier Ab Amino acids for the preparation of a beverage
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
AT393080B (de) * 1988-11-25 1991-08-12 Lubec Gert Pharmazeutische verwendung von arginin (salzen)
AT393079B (de) * 1989-03-06 1991-08-12 Lubec Gert Pharmazeutische verwendung von agmatin
SE462463B (sv) * 1988-12-02 1990-07-02 Decken Alexandra V D Livs- och fodermedel innehaallande ketosyror
JP2522034B2 (ja) * 1988-12-27 1996-08-07 味の素株式会社 α−ケト酸・アミノ酸塩化合物及びその製造方法
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
DE69530067T2 (de) 1994-10-07 2004-01-29 Firmenich & Cie Aromazusammensetzungen und aromatisierungsverfahren
US5591736A (en) * 1995-07-03 1997-01-07 The Johns Hopkins University Method of retarding the progression of chronic renal failure
WO2002081020A2 (en) * 2001-04-04 2002-10-17 Critical Therapeutics, Inc. Method for preventing acute renal failure
JP4778913B2 (ja) * 2004-11-15 2011-09-21 協和発酵バイオ株式会社 L−オルニチン結晶およびその製造方法
GB0426141D0 (en) * 2004-11-26 2004-12-29 Ucl Biomedica Plc Treatment
PL1824563T3 (pl) * 2004-11-26 2010-07-30 Ucl Business Plc Kompozycje zawierające ornitynę i fenylooctan lub fenylomaślan do leczenia encefalopatii wątrobowej
SG174982A1 (en) 2009-04-03 2011-11-28 Ocera Therapeutics Inc L-ornithine phenyl acetate and methods of making thereof
JP5749255B2 (ja) 2009-06-08 2015-07-15 ユーシーエル ビジネス ピーエルシー L−オルニチンフェニル酢酸塩を用いる門脈圧亢進の治療及び肝機能の修復
JP6087284B2 (ja) 2010-10-06 2017-03-01 オセラ セラピューティクス, インコーポレイテッド L−オルニチンフェニルアセテートを製造するための方法
IL281349B (en) 2014-11-24 2022-09-01 Ucl Business Ltd Treatment of diseases related to hepatic stellate cell activity using ammonia-lowering treatments
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
CN106674057A (zh) * 2015-11-09 2017-05-17 江西乐维生物药业有限公司 L-精氨酸a-酮基异己酸盐的制备方法
US11219611B2 (en) 2015-11-13 2022-01-11 Ocera Therapeutics, Inc. Formulations of L-ornithine phenylacetate
WO2017090007A1 (en) * 2015-11-29 2017-06-01 Rao M Surya Compositions and methods for the treatment of urea cycle disorders and hepatic diseases
CA3063134A1 (en) 2017-05-11 2018-11-15 Ocera Therapeutics, Inc. Processes of making l-ornithine phenylacetate
US12109254B2 (en) 2017-11-29 2024-10-08 Edgar Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
EP3716966A4 (en) 2017-11-29 2021-08-18 Hull, Edgar, L., Jr. ALPHA-KETO ACID COMPOSITIONS FOR THE TREATMENT OF HYPOALBUMINEMIA

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA814483A (en) * 1969-06-03 Abe Kyuji L-ornithine-l-aspartate
GB1034358A (en) 1963-05-01 1966-06-29 Chugai Pharmaceutical Co Ltd Body-protein-biosynthesis promoting composition
FR1432756A (fr) 1965-02-11 1966-03-25 D Opochimiotherapie Lab Pyruvates d'amino-acides et leur procédé de préparation
US3441650A (en) * 1965-07-23 1969-04-29 Lab Jacques Logeais Sa Therapy of ammonical intoxications by di-l-ornithine alpha-ketoglutarate
DE2335215B2 (de) 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
US4100161A (en) * 1974-04-15 1978-07-11 The Johns Hopkins University Promotion of protein synthesis and suppression of urea formation in the body by keto analogs of essential amino acids
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same

Also Published As

Publication number Publication date
IE790993L (en) 1979-09-17
FI72118B (fi) 1986-12-31
GB2017094B (en) 1982-07-07
GB2017094A (en) 1979-10-03
DE2910221C2 (da) 1988-04-28
ES478710A1 (es) 1980-01-16
JPS5838421B2 (ja) 1983-08-23
AU517505B2 (en) 1981-08-06
FI790901A7 (fi) 1979-09-18
LU81057A1 (fr) 1979-09-07
NL7902136A (nl) 1979-09-19
US4228099A (en) 1980-10-14
IT1202904B (it) 1989-02-15
AU4515479A (en) 1979-09-20
IT7921071A0 (it) 1979-03-16
JPS54163518A (en) 1979-12-26
FR2419723B1 (da) 1982-10-29
FI72118C (fi) 1987-04-13
DK153542B (da) 1988-07-25
BE874900A (fr) 1979-07-16
FR2419723A1 (fr) 1979-10-12
SE7902401L (sv) 1979-10-16
NO151119B (no) 1984-11-05
DE2910221A1 (de) 1979-09-20
CA1115729A (en) 1982-01-05
NO790903L (no) 1979-09-18
NO151119C (no) 1985-02-13
SE446724B (sv) 1986-10-06
IE48336B1 (en) 1984-12-12
DK153542C (da) 1988-12-05

Similar Documents

Publication Publication Date Title
DK110879A (da) Ornithin-og argininsalte af forgrenede keto-syrer fremgangsmaade til fremstilling deraf samt deres anvendelse
DK258479A (da) Spiro-oxazoldindioner fremgangsmaade til deres fremstilling samt deres anvendelse og mellemprodukter til udoevelse af fremgangsmaaden
DK157860C (da) Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf
DK266479A (da) Fremgangsmaade til fremstilling af 3-aminopropoxyarylderivater
DK488078A (da) Quinazolin-derivater fremgangsmaade til deres fremstilling samt deres anvendelse
DK162225C (da) Fremgangsmaade til fremstilling af lactoner af cyclopropancarboxylsyrer
DK303079A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK18179A (da) 2-pyrrolidon-forbindelser og fremgangsmaade til deres fremstilling samt deres anvendelse til fremstilling af farmakologisk aktive forbindelser
DK95678A (da) Tetrahydrofuranetherderivater fremgangsmaade til fremtilling deraf samt deres anvendelse som herbicider
DK158836C (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive anthraquinonderivater
DK410878A (da) Paa siliciumdioxid baserede skumbekaempende kompostitoner med forbedret stabilitet fremgangsmaade til deres fremstilling samt deres anvendelse
DK21777A (da) Fremgangsmade til fremstilling af oxigenerede n-aryl-diazacyler samt salte deraf
DK186179A (da) Fremgangsmaade til fremstilling af carbapenemderivater
DK537677A (da) Propionsyrederivater samt fremgangsmaade til deres fremstilling
DK184579A (da) Estere af substituerede 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepiner,fremgangsmaade til deres fremstilling samt deres anvendelse
DK69179A (da) Substituerede 2-phenylimino-imidazolidiner syreadditionssalte heraf samt fremgansmaade til fremstilling heraf
DK397678A (da) Substituerede benzotrin-1-oxider til bekaempelse af plantebakterioser samt fremgangsmaade til deres fremstilling
DK294579A (da) Antiprotozoelle oxadiazolderivater fremgangsmaade til deres fremstilling samt deres anvendelse
DK20578A (da) Fremgangsmaade til femstilling af aliphatisk substituerede 4-(phenyl)-1-aza-cyloalkaner samt anvendelse deraf
DK160281C (da) Fremgangsmaade til fremstilling af steroid-s-thioesterderivater
DK62878A (da) Fremgangsmaade til fremstilling af benzoheterocyclylglyoxylsyrederivater samt salte deraf
DK86979A (da) Substituerede pyrrolidinoner med herbicid virkning samt fremgangsmaade til fremstilling af saadanne forbindelser
DK333679A (da) Substituerede pyrazolderivater samt fremgangsmaade til deres fremstilling
DK159144C (da) Fremgangsmaade til fremstilling af optisk aktive aryloxyalkansyrederivater
DK206377A (da) Substituerede pyrazolopyriminer fremgangsmade til deres fremstilling samt deres anvendelse

Legal Events

Date Code Title Description
PUP Patent expired